Cancer screening with FDG-PET

被引:0
|
作者
Ide, M [1 ]
机构
[1] HIMEDIC Imaging Ctr Lake Yamanaka, Yamanashi 4010502, Japan
关键词
neoplasms; screening; fludeoxyglucose; positron emission tomography;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim. Thi study is based on medical health check-up and cancer screening on of a medical health club using PET, MRI, spiral CT and other conventional examinations. Methods. Between October 1994 and June 2005, 9 357 asymptomatic members of the health club participated in 24 772 screening session (5 693 men and 3 664 women, mean age was 52.2 +/- 10.4 years). Results. Malignant tumors were discovered in 296 of the 9 357 participants (3.16%) and 24772 screening sessions (1.19%). The detection rate of our program is much higher than that of mass screening in Japan. The thyroid, lung, colon and breast cancers were PET positive, but the prostate, renal and bladder cancers were generally PET negative. Conclusion. FDG-PET has the potential to detect a wide variety of cancers at curable stages in asymptomatic Individuals. To reduce false-positive and false-negative results of PET examination, there is a need for experienced radiologist and/or oncologists who had training in the wide aspect of FDG-PET. FDG-PET has limitations in the detection of urological cancers, cancers of low cell density, small cancers and hypometabolic or FDG non-avid cancers. Therefore, conventional examinations and/or PET/CT are also needed for cancer screening in association with FDG-PET.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 50 条
  • [11] Evaluation of whole-body FDG-PET in breast cancer screening
    Nishizawa, S.
    Kodama, H.
    Okada, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [12] The role of FDG-PET in screening for distant metastases in head and neck cancer
    de Bree, R.
    [J]. ORAL ONCOLOGY, 2007, : 99 - 99
  • [13] Occult myofibroblastic sarcoma detected on FDG-PET performed for cancer screening
    Morii, Takeshi
    Mochizuki, Kazuo
    Sano, Hideto
    Fujino, Takashi
    Harasawa, Arimi
    Satomi, Kazuhiko
    [J]. ANNALS OF NUCLEAR MEDICINE, 2008, 22 (09) : 811 - 815
  • [14] Occult myofibroblastic sarcoma detected on FDG-PET performed for cancer screening
    Takeshi Morii
    Kazuo Mochizuki
    Hideto Sano
    Takashi Fujino
    Arimi Harasawa
    Kazuhiko Satomi
    [J]. Annals of Nuclear Medicine, 2008, 22
  • [15] THE ROLE OF THE FDG-PET SCAN IN THE NELSON LUNG CANCER SCREENING TRIAL
    Westeinde, Susan V.
    De Koning, Harry J.
    Thunnissen, Frederik B.
    Oudkerk, Matthijs
    Groen, Harry J. M.
    Lammers, Jan-Willem J.
    Weenink, Carla
    Vernhout, Rene
    Nackaerts, Kristiaan
    Mali, Willem
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S350 - S350
  • [16] FDG-PET imaging in duodenal cancer
    Naoto Watanabe
    Shinichi Hayashi
    Hiroshi Kato
    Masashi Shimizu
    Yuichi Kamisaki
    Kyo Noguchi
    Mika Kishida
    Ichiro Matsunari
    Kinichi Hisada
    Hikaru Seto
    [J]. Annals of Nuclear Medicine, 2004, 18 : 351 - 353
  • [17] FDG-PET in the evaluation of cervical cancer
    Macapinlac, HA
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : S171 - S172
  • [18] Cavitary lung cancer and FDG-PET
    Triponez, F
    de Perrot, M
    Orrit, J
    Robert, J
    Spiliopoulos, A
    [J]. ANNALES DE CHIRURGIE, 2002, 127 (05): : 403 - 404
  • [19] Effectiveness of FDG-PET in Screening of Synchronous Cancer of Other Organs in Patients with Esophageal Cancer
    Miyazaki, Tatsuya
    Sohda, Makoto
    Higuchi, Tetsuya
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Sakai, Makoto
    Yokobori, Takehiko
    Nakajima, Masanobu
    Fukuchi, Minoru
    Tsushima, Yoshito
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    [J]. ANTICANCER RESEARCH, 2014, 34 (1A) : 283 - 287
  • [20] FDG-PET Imaging in Cervical Cancer
    Gandy, Nemi
    Arshad, Mubarik A.
    Park, Won-Ho E.
    Rockall, Andrea G.
    Barwick, Tara D.
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2019, 49 (06) : 461 - 470